Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Jacobs

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|April 6, 2017
Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated NeuropathiesWjr Fokkink, Bcp Koch, Crb Ramakers, et al.
Annals of Neurology|August 1, 1995
Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicryP G Oomes, B C Jacobs, M P Hazenberg, et al.
Neurology|March 16, 2011
Early recognition of poor prognosis in Guillain-Barre syndromeC Walgaard, H F Lingsma, L Ruts, et al.
Journal of Neuroimmunology|December 31, 1997
Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosidesB C Jacobs, G M O'Hanlon, E G Breedland, et al.
The Journal of Infectious Diseases|March 1, 1997
Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndromeB C Jacobs, M P Hazenberg, P A van Doorn, et al.
The Journal of Infectious Diseases|January 7, 1998
Differences in N-acetylmuramyl-L-alanine amidase and lysozyme in serum and cerebrospinal fluid of patients with bacterial meningitisM A Hoijer, R de Groot, L van Lieshout, et al.
Leukemia|March 1, 1993
Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markersH J Adriaansen, B C Jacobs, M C Kappers-Klunne, et al.
European Journal of Neurology|June 14, 2020
Guillain-Barré syndrome after SARS-CoV-2 infectionD Kilinc, S van de Pasch, A Y Doets, et al.
Journal of Neuroimmunology|December 4, 2001
Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The NetherlandsC W Ang, M Koga, B C Jacobs, et al.
Neurology|March 2, 2011
Recognizing Guillain-Barre syndrome in preschool childrenJ Roodbol, M C Y de Wit, C Walgaard, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|April 6, 2017
Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated NeuropathiesWjr Fokkink, Bcp Koch, Crb Ramakers, et al.
Annals of Neurology|August 1, 1995
Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicryP G Oomes, B C Jacobs, M P Hazenberg, et al.
Neurology|March 16, 2011
Early recognition of poor prognosis in Guillain-Barre syndromeC Walgaard, H F Lingsma, L Ruts, et al.
Journal of Neuroimmunology|December 31, 1997
Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosidesB C Jacobs, G M O'Hanlon, E G Breedland, et al.
The Journal of Infectious Diseases|March 1, 1997
Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndromeB C Jacobs, M P Hazenberg, P A van Doorn, et al.
The Journal of Infectious Diseases|January 7, 1998
Differences in N-acetylmuramyl-L-alanine amidase and lysozyme in serum and cerebrospinal fluid of patients with bacterial meningitisM A Hoijer, R de Groot, L van Lieshout, et al.
Leukemia|March 1, 1993
Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markersH J Adriaansen, B C Jacobs, M C Kappers-Klunne, et al.
European Journal of Neurology|June 14, 2020
Guillain-Barré syndrome after SARS-CoV-2 infectionD Kilinc, S van de Pasch, A Y Doets, et al.
Journal of Neuroimmunology|December 4, 2001
Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The NetherlandsC W Ang, M Koga, B C Jacobs, et al.
Neurology|March 2, 2011
Recognizing Guillain-Barre syndrome in preschool childrenJ Roodbol, M C Y de Wit, C Walgaard, et al.
Pageof 8